Skip to main content
Egyptian Journal of Radiology and Nuclear Medicine
Fig. 5 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 5

From: "Sinopharm", "Oxford-AstraZeneca", and "Pfizer-BioNTech" COVID-19 vaccinations: testing efficacy using lung CT-volumetry with comparative analysis of variance (ANOVA)

Fig. 5

A 58-year-old female patient with negative past medical history and had received “Phizer-Biontech” vaccine then got COVID-19 infection. A, B Axial chest CT cuts (lung window) showed bilateral mainly peripheral located ground-glass pneumonic patches. C CT-Volumetry of the pathological lung parts averages 381 cc. D CT-Volumetry of total lung volume averages 3058 cc. So, only 10% of the lung parenchyma was diseased (Score 1)

Back to article page